UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Baloxavir Marboxil for Prophylaxis against Influenza in Household Contacts

The New England journal of medicine, 2020-07, Vol.383 (4), p.309-320

2020

Volltextzugriff (PDF)

Effect of seasonal vaccination on the selection of influenza A/H3N2 epidemic variants

Vaccine, 2017-01, Vol.35 (2), p.255-263

2017

Volltextzugriff (PDF)

Laninamivir octanoate: a new long-acting neuraminidase inhibitor for the treatment of influenza

Expert review of anti-infective therapy, 2011-10, Vol.9 (10), p.851-857

2011

Volltextzugriff (PDF)

High genetic stability in MDCK-SIAT1 passaged human influenza viruses

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2019-03, Vol.25 (3), p.222-224

2019

Volltextzugriff (PDF)

Is seasonal vaccination a contributing factor to the selection of influenza epidemic variants?

Human vaccines & immunotherapeutics, 2018-03, Vol.14 (3), p.518-522

2018

Volltextzugriff (PDF)

Consecutive influenza surveillance of neuraminidase mutations and neuraminidase inhibitor resistance in Japan

Influenza and other respiratory viruses, 2019-03, Vol.13 (2), p.115-122

2019

Volltextzugriff (PDF)

Spread of predominant neuraminidase and hemagglutinin co-mutations in the influenza A/H3N2 virus genome

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2018-03, Vol.24 (3), p.193-198

2018

Volltextzugriff (PDF)

A randomized, controlled trial comparing traditional herbal medicine and neuraminidase inhibitors in the treatment of seasonal influenza

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2012-08, Vol.18 (4), p.534-543

2012

Volltextzugriff (PDF)

Post-vaccination antibody evaluation for nosocomial SARS-CoV-2 delta variant breakthrough infection

PloS one, 2022-07, Vol.17 (7), p.e0272056-e0272056

2022

Volltextzugriff (PDF)

Post-vaccination antibody evaluation for nosocomial SARS-CoV-2 delta variant breakthrough infection

PloS one, 2022-07, Vol.17 (7), p.e0272056

2022

Volltextzugriff (PDF)

Duration of fever and other symptoms after the inhalation of laninamivir octanoate hydrate for influenza treatment; comparison among the four Japanese influenza seasons from 2011-2012 to 2014-2015

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2016-09, Vol.22 (9), p.605-610

2016

Volltextzugriff (PDF)

Genetic testing and serological screening for SARS-CoV-2 infection in a COVID-19 outbreak in a nursing facility in Japan

BMC infectious diseases, 2021-03, Vol.21 (1), p.263-263, Article 263

2021

Volltextzugriff (PDF)

In vitro neuraminidase inhibitory activities of four neuraminidase inhibitors against influenza viruses isolated in the 2010–2011 season in Japan

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2012-08, Vol.18 (4), p.529-533

2012

Volltextzugriff (PDF)

In vitro neuraminidase inhibitory concentration (IC50) of four neuraminidase inhibitors in the Japanese 2018–19 season: Comparison with the 2010–11 to 2017–18 seasons

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2020-08, Vol.26 (8), p.775-779

2020

Volltextzugriff (PDF)

In vitro neuraminidase inhibitory activity of four neuraminidase inhibitors against clinical isolates of the influenza virus circulating in the Japanese 2013–2014 season

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2015-09, Vol.21 (9), p.634-638

2015

Volltextzugriff (PDF)

Duration of fever and other symptoms after the inhalation of laninamivir octanoate hydrate: A study of the 2017/18 and 2018/19 seasons and comparison with the 2011/12 to 2016/17 Japanese influenza seasons

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2022-07, Vol.28 (7), p.890-895

2022

Volltextzugriff (PDF)

Laninamivir octanoate for post-exposure prophylaxis of influenza in household contacts: a randomized double blind placebo controlled trial

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2013, Vol.19 (4), p.740-749

2013

Volltextzugriff (PDF)

Duration of fever and other symptoms after the inhalation of laninamivir octanoate hydrate; comparison of the 2011/12 to 2015/16 Japanese influenza seasons

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2017-09, Vol.23 (9), p.627-633

2017

Volltextzugriff (PDF)

In vitro neuraminidase inhibitory activity of four neuraminidase inhibitors against clinical isolates of influenza virus in the Japanese 2012–2013 season

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2015-01, Vol.21 (1), p.39-42

2015

Volltextzugriff (PDF)

In vitro neuraminidase inhibitory concentration (IC50 ) of four neuraminidase inhibitors against clinical isolates of the influenza viruses circulating in the 2010-2011 to 2014-2015 Japanese influenza seasons

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2016-09, Vol.22 (9), p.599-604

2016

Volltextzugriff (PDF)

In vitro neuraminidase inhibitory concentration (IC50) of four neuraminidase inhibitors in the Japanese 2017–18 season: Comparison with the 2010–11 to 2016–17 seasons

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2019-08, Vol.25 (8), p.649-652

2019

Volltextzugriff (PDF)

A Comparison of the Effectiveness of Oseltamivir for the Treatment of Influenza A and Influenza B: A Japanese Multicenter Study of the 2003–2004 and 2004–2005 Influenza Seasons

Clinical infectious diseases, 2006-08, Vol.43 (4), p.439-444

2006

Volltextzugriff (PDF)

Clinical outcome of laninamivir octanoate hydrate for influenza in the 2013–2014 Japanese season

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2015-11, Vol.21 (11), p.802-807

2015

Volltextzugriff (PDF)

Duration of fever and other symptoms after the inhalation of laninamivir octanoate hydrate in the 2016/17 Japanese influenza season; comparison with the 2011/12 to 2015/16 seasons

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2018-09, Vol.24 (9), p.718-724

2018

Volltextzugriff (PDF)

Long-acting Neuraminidase Inhibitor Laninamivir Octanoate as Post-exposure Prophylaxis for Influenza

Clinical infectious diseases, 2016-08, Vol.63 (3), p.330-337

2016

Volltextzugriff (PDF)

1 – 25 von 308

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(210)
Mit Volltextzugriff
(240)

Publikationsform

Sprache

Englisch
(253)
Japanisch
(79)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Baloxavir Marboxil for Prophylaxis against Influenza in Household Contacts

Effect of seasonal vaccination on the selection of influenza A/H3N2 epidemic variants

Laninamivir octanoate: a new long-acting neuraminidase inhibitor for the treatment of influenza

High genetic stability in MDCK-SIAT1 passaged human influenza viruses

Is seasonal vaccination a contributing factor to the selection of influenza epidemic variants?

Consecutive influenza surveillance of neuraminidase mutations and neuraminidase inhibitor resistance in Japan

Spread of predominant neuraminidase and hemagglutinin co-mutations in the influenza A/H3N2 virus genome

A randomized, controlled trial comparing traditional herbal medicine and neuraminidase inhibitors in the treatment of seasonal influenza

Post-vaccination antibody evaluation for nosocomial SARS-CoV-2 delta variant breakthrough infection

Post-vaccination antibody evaluation for nosocomial SARS-CoV-2 delta variant breakthrough infection

Duration of fever and other symptoms after the inhalation of laninamivir octanoate hydrate for influenza treatment; comparison among the four Japanese influenza seasons from 2011-2012 to 2014-2015

Genetic testing and serological screening for SARS-CoV-2 infection in a COVID-19 outbreak in a nursing facility in Japan

In vitro neuraminidase inhibitory activities of four neuraminidase inhibitors against influenza viruses isolated in the 2010–2011 season in Japan

In vitro neuraminidase inhibitory concentration (IC50) of four neuraminidase inhibitors in the Japanese 2018–19 season: Comparison with the 2010–11 to 2017–18 seasons

In vitro neuraminidase inhibitory activity of four neuraminidase inhibitors against clinical isolates of the influenza virus circulating in the Japanese 2013–2014 season

Duration of fever and other symptoms after the inhalation of laninamivir octanoate hydrate: A study of the 2017/18 and 2018/19 seasons and comparison with the 2011/12 to 2016/17 Japanese influenza seasons

Laninamivir octanoate for post-exposure prophylaxis of influenza in household contacts: a randomized double blind placebo controlled trial

Duration of fever and other symptoms after the inhalation of laninamivir octanoate hydrate; comparison of the 2011/12 to 2015/16 Japanese influenza seasons

In vitro neuraminidase inhibitory activity of four neuraminidase inhibitors against clinical isolates of influenza virus in the Japanese 2012–2013 season

In vitro neuraminidase inhibitory concentration (IC50 ) of four neuraminidase inhibitors against clinical isolates of the influenza viruses circulating in the 2010-2011 to 2014-2015 Japanese influenza seasons

In vitro neuraminidase inhibitory concentration (IC50) of four neuraminidase inhibitors in the Japanese 2017–18 season: Comparison with the 2010–11 to 2016–17 seasons

A Comparison of the Effectiveness of Oseltamivir for the Treatment of Influenza A and Influenza B: A Japanese Multicenter Study of the 2003–2004 and 2004–2005 Influenza Seasons

Clinical outcome of laninamivir octanoate hydrate for influenza in the 2013–2014 Japanese season

Duration of fever and other symptoms after the inhalation of laninamivir octanoate hydrate in the 2016/17 Japanese influenza season; comparison with the 2011/12 to 2015/16 seasons

Long-acting Neuraminidase Inhibitor Laninamivir Octanoate as Post-exposure Prophylaxis for Influenza

Suchergebnisse filtern